Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Myriad Genetics, Inc. (MYGN) vs Exagen Inc. (XGN)

Myriad Genetics, Inc. and Exagen Inc. are both Diagnostics & Research companies. Myriad Genetics, Inc. is the larger, with a market value of $396.0M against $233.3M — 1.7× the size. Exagen Inc. grew revenue faster over the last twelve months: 20.8% against −3.16%. Myriad Genetics, Inc. has the higher net margin (−14.0% vs −26.6%) and the higher return on invested capital (−19.9% vs −68.3%). Across the 18 metrics below, Myriad Genetics, Inc. leads on 12 and Exagen Inc. on 6.

Valuation

Metric MYGN XGN Diagnostics & Research median
P/E n/m n/m 33.95
P/S 0.49 2.96 4.87
P/B 1.30 17.25 3.12
Price to free cash flow n/m n/m 34.02
EV/EBITDA n/m n/m 25.20
EV/Sales 0.57 2.96 5.66
Earnings yield (28.54%) (9.29%) (1.75%)
Free cash flow yield (3.59%) (3.60%) (0.13%)

Profitability

Metric MYGN XGN Diagnostics & Research median
Gross margin 68.83% 58.64% 50.89%
Operating margin (12.22%) (18.58%) (8.57%)
Net margin (13.96%) (26.61%) (6.37%)
Free cash flow margin (1.76%) (10.66%) 0.00%
Return on equity (32.54%) (113.82%) (2.92%)
Return on assets (17.11%) (34.19%) (6.71%)
Return on invested capital (19.92%) (68.33%) 0.00%

Growth

Metric MYGN XGN Diagnostics & Research median
Revenue growth (TTM) (3.16%) 20.83% 7.69%
EPS growth (last fiscal year) (180.14%) (12.05%) —
Revenue growth, 5-year CAGR 3.61% 9.66% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MYGN XGN Diagnostics & Research median
Debt to equity 0.40 2.00 0.11
Current ratio 2.21 3.18 2.02
Net debt to EBITDA 2.11 0.68 0.78

Dividend

Metric MYGN XGN Diagnostics & Research median
Dividend yield — — 0.70%
Payout ratio 0.00 0.00 0.00

Size

Metric MYGN XGN Diagnostics & Research median
Market cap 395.99m 233.29m 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack